Drug developer Allergy Therapeutics Plc said a study on suitable doses of its therapy to treat grass allergic rhinitis, or hay fever, did not find a recommended dose for a late-stage trial.
<span class="articleLocation”>Circassia Pharmaceuticals lost nearly two-thirds of its value on Monday as its experimental cat allergy treatment failed in a late-stage trial, dealing a major blow to the high-profile British biotech company. Circassia listed on the London stock market in March 2014 in Britain’s largest biotech flotation for decades and last year it expanded by […]
Adamis Pharmaceuticals Corp said the U.S. Food and Drug Administration rejected its emergency treatment for acute anaphylaxis, a severe allergic reaction, for the second time.
Commonly used drugs for problems such as colds and heart disease have long been linked to cognitive impairment and dementia. New evidence may help explain the connection.
French drugmaker Sanofi SA said it was voluntarily recalling all its Auvi-Q injections in the United States to treat patients with severe allergic reactions. The company said on Wednesday its U.S. unit was recalling the injections as they could potentially deliver an inaccurate dose. Auvi-Q is designed to treat anaphylaxis, a potentially fatal allergic reaction, […]
Dublin, Ireland-based Perrigo Company plc (PRGO) announced today that it will take a number of actions, including layoffs, to increase profitability and help fend off a hostile takeover by Canonsburg, Penn. and UK-based Mylan N.V. The company plans to consolidate its global supply chain, operations and procurement management activities into a single global center […]
Japan’s Astellas is seeking more deals to refill its drug pipeline as the pharmaceutical company created through a merger 10 years ago explores opportunities in both established and new therapy areas. “We’re never satisfied with what we have, so we are looking at strategies to augment the portfolio. Nothing is off the table for […]
HERSHEY, Pa. and ROCKVILLE, Md. and TOKYO, Oct. 9, 2015 /PRNewswire/ — Immunomic Therapeutics, Inc. (“Immunomic Therapeutics”), a company developing next generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. (“Astellas”) today announced they have entered into an exclusive worldwide license agreement to the LAMP-vax products for the treatment or prevention of any […]
Children who eat certain types of fish may be less likely to develop nasal allergies, according to a study from Sweden. Researchers studied what children ate at age eight and then monitored whether they developed nasal inflammation due to allergies or colds by age 16. Regular consumption of oily fish like salmon was linked a […]